Arrowstreet Capital Limited Partnership Takes $205,000 Position in Grail, Inc. (NASDAQ:GRAL)

Arrowstreet Capital Limited Partnership acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 11,501 shares of the company's stock, valued at approximately $205,000.

Other hedge funds have also added to or reduced their stakes in the company. Douglas Lane & Associates LLC bought a new stake in Grail during the fourth quarter worth $3,034,000. A. D. Beadell Investment Counsel Inc. acquired a new position in shares of Grail in the fourth quarter valued at approximately $430,000. FNY Investment Advisers LLC acquired a new stake in Grail during the 4th quarter worth approximately $26,000. 180 Wealth Advisors LLC bought a new stake in Grail during the 4th quarter worth approximately $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail in the 4th quarter valued at approximately $387,000.

Analyst Ratings Changes

Separately, Morgan Stanley raised their price objective on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Stock Up 4.3 %

GRAL traded up $1.08 during midday trading on Tuesday, reaching $25.93. The company had a trading volume of 1,029,383 shares, compared to its average volume of 1,225,125. The business has a 50-day moving average price of $33.33 and a two-hundred day moving average price of $23.34. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Remove Ads

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analysts' expectations of $35.33 million. As a group, equities analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Activity at Grail

In related news, CFO Aaron Freidin sold 1,816 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,550 shares of company stock worth $360,436 in the last ninety days.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.